Novo Nordisk A/S (NVO) 137.47 2.975

Novo Nordisk A/S ADS
(NVO) 137.47 2.975

Last Trade:	137.475	Day Range:	135.99 - 137.48
Trade Time:	11:02AM	52wk Range:	94.58 - 135.68
Prev. Close:	134.50	Market Cap:	79.74B
Open:	136.42	Div Yield:	0
Volume:	73544	PE:
EPS:	0.00

The Latest On NVO

Novo Nordisk Reports 19% Rise In Q4 Profit, Lifts Forecast 2/2/12 5:55am

Escaping Europe's Escapades In The Garden of EDEN 1/31/12 3:00am

9 Option Trades on Dividend Stocks & Gold 8/30/11 11:41pm

3 Top Dividend Growth Stocks 8/30/11 1:08pm

GlaxoSmithKline and Isis Pharmaceuticals partnership shouldn't be overlooked as a long-term 5/18/11 5:29am

CEOWORLD Top 10 Tech Stocks Winning 52-Week Highs- ABB, IBM, ORCL, NVO, BTI, SAP, ERIC, VMW, ACN and MA 4/26/11 4:29am

JP Morgan Downgrades NVO To Neutral 4/11/11 5:19am

Novo-Nordisk's Victoza Approved For Type-2 Diabetes In China (NVO). 3/22/11 6:45am

Portfolio Construction Philosophy 2/22/11 8:15am

Mad Money Lightning Round: Cramer Advises Investors To Buy Apple (NVO, FNSR, ARG, AAPL, OH) 2/14/11 12:47am

Cost Control Helps Amylin Cut Loss - Analyst Blog 1/27/11 10:31am

Cost Control Helps Amylin Cut Loss - Analyst Blog 1/27/11 10:15am

Novo Nordisk Reports 19% Rise In Q4 Profit, Lifts Forecast 2/2/12

Escaping Europe's Escapades In The Garden of EDEN 1/31/12

9 Option Trades on Dividend Stocks & Gold 8/30/11

3 Top Dividend Growth Stocks 8/30/11

GlaxoSmithKline and Isis Pharmaceuticals partnership shouldn't be overlooked as a long-term 5/18/11

CEOWORLD Top 10 Tech Stocks Winning 52-Week Highs- ABB, IBM, ORCL, NVO, BTI, SAP, ERIC, VMW, ACN and MA 4/26/11

JP Morgan Downgrades NVO To Neutral 4/11/11

Novo-Nordisk's Victoza Approved For Type-2 Diabetes In China (NVO). 3/22/11

Portfolio Construction Philosophy 2/22/11

Mad Money Lightning Round: Cramer Advises Investors To Buy Apple (NVO, FNSR, ARG, AAPL, OH) 2/14/11

Cost Control Helps Amylin Cut Loss - Analyst Blog 1/27/11

Escaping Europe's Escapades In The Garden of EDEN 1/31/12

Mad Money Lightning Round: Cramer Advises Investors To Buy Apple (NVO, FNSR, ARG, AAPL, OH) 2/14/11

Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield (TPI, RELV, TEVA, NVO) 12/30/10

Stocks Rip Higher (SPY, DAL, AMR, NVO, URI) 10/20/10

Top Performing Industries For October 20 (DAL, NVO, SHZ, CNTY) 10/20/10

Top 5 Large-Cap NYSE Stocks In The Healthcare Sector With The Highest Return On Equity (GSK, LLY, AZN, ACL, NVO) 6/7/10

NVO Initiated With Hold 3/31/10

Top 5 NYSE Stocks In the Healthcare Sector With The Highest ROA (NVO, ACL, HLF, AZN, VAR) 3/3/10

Stocks That Created New 52-Week Highs (AMLN, CNXT, GOODO, NRGP, INSW) 1/26/10

Benzinga’s Volume Movers (VLTR, AMLN, PRXL, ICLR, ZION) 1/26/10

Going Nordic In Search Of ETF Opportunities 1/16/10

JP Morgan Downgrades NVO To Neutral 4/11/11

Goldman Ups NVO To Buy 1/25/11

Deutsche Bank Downgrades NVO To Sell 1/14/11

Benzinga's Top Upgrades (BRCM, NVO, ARG, PG) 12/10/10

Citigroup Upgrades NVO To Buy 12/10/10

Morgan Stanley Downgrades NVO To Equal Weight 11/18/10

JP Morgan Upgrades NVO To Overweight 10/28/10

Societe Generale Upgrades NVO To Hold 10/19/10

NVO Initiated With Hold 3/31/10

Benzinga’s Top Downgrades (PAYX, NVO, TEVA, PVA, PRSC) 1/15/10

Trade NVO
NOW!

Partner Headlines

YCHART OF THE DAY: Facebook's $75-100 Billion Market Cap on Just $6.3 Billion in Assets: Customers Create All the Value 2/10/12

GlaxoSmithKline Swings To Profit But Shy Of Estimates 2/7/12

Novo Nordisk Posts Solid 4Q - Analyst Blog 2/6/12

The Curse of Amylin's Diabetes Drug Approval 2/6/12

10 Sleazy Celebrity Endorsements 2/3/12

Emerging Markets, Industrials, Tech Fuel Fund Gains 2/2/12

Third Time Lucky for Amylin's Bydureon - Analyst Blog 1/30/12

Third Time's The Charm for Approval of Amylin Diabetes Drug 1/27/12

The 5 Dumbest Things on Wall Street: Jan. 20 1/20/12

Press Releases

Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle 1/23/12 Newswire Story

Novo Nordisk Named to FORTUNE'S '100 Best Companies to Work For' List for Fourth Consecutive Year 1/19/12 Newswire Story

Novo Nordisk Partners with Paula Deen and Sons, Bobby and Jamie Deen, on National Diabetes Initiative 1/17/12 Newswire Story

Bio Solutions Corp./Type2 Defense: Product Update 9/6/11 Marketwire Story

Walgreens and Novo Nordisk Team Up to Provide Free Complete Needle™ Collection & Disposal System for Patients who Self-Inject 8/30/11 Business Wire Story

Photo Release -- Sharps Compliance Announces Walgreens and Novo Nordisk Promotion of its Complete Needle(TM) Collection & Disposal System 8/30/11 GlobeNewswire Story

Adimab Announces New Discovery Programs with Biogen Idec and Novo Nordisk 8/30/11 Business Wire Story

Get the latest NVO stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Novo Nordisk A/S ADS stock price.

Novo Nordisk A/S ADS by YCharts

Novo Nordisk A/S (NVO) 137.47 2.975

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On NVO

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social